4D Molecular Therapeutics Inc (FDMT)
7.99
-0.42
(-4.99%)
USD |
NASDAQ |
Nov 21, 16:00
7.975
-0.02
(-0.19%)
Pre-Market: 20:00
4D Molecular Therapeutics Total Liabilities (Quarterly): 51.08M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 51.08M |
| June 30, 2024 | 31.78M |
| March 31, 2024 | 29.32M |
| December 31, 2023 | 32.06M |
| September 30, 2023 | 31.68M |
| June 30, 2023 | 27.36M |
| March 31, 2023 | 25.42M |
| December 31, 2022 | 30.51M |
| September 30, 2022 | 28.72M |
| June 30, 2022 | 30.42M |
| Date | Value |
|---|---|
| March 31, 2022 | 28.87M |
| December 31, 2021 | 34.38M |
| September 30, 2021 | 16.48M |
| June 30, 2021 | 14.29M |
| March 31, 2021 | 27.68M |
| December 31, 2020 | 31.94M |
| September 30, 2020 | 28.04M |
| December 31, 2019 | 131.20M |
| June 30, 2019 | 122.80M |
| December 31, 2018 | 124.56M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
14.29M
Minimum
Jun 2021
131.20M
Maximum
Dec 2019
35.07M
Average
29.87M
Median
Total Liabilities (Quarterly) Benchmarks
| Regeneron Pharmaceuticals Inc | 8.116B |
| Ocular Therapeutix Inc | 138.35M |
| NovaBay Pharmaceuticals Inc | 2.805M |
| Palatin Technologies Inc | 11.10M |
| iBio Inc | 6.763M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 604.03M |
| Shareholders Equity (Quarterly) | 552.95M |
| Current Ratio | 17.33 |